Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,353.60
(
-0.01%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.60
(
-0.81%
)
Bitcoin
76,889.54
(
-0.67%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 40508

Wednesday, 06/20/2012 4:14:57 PM

Wednesday, June 20, 2012 4:14:57 PM

Post# of 257580
NVO is the Genentech of Europe in terms of having great success by hiring the smartest scientists (#msg-16127025). NVO’s annual employee turnover in R&D is only 3%, and only 1% of those leaving are people the company wants to keep.

Source: http://www.forbes.com/sites/matthewherper/2012/06/20/can-drug-companies-fix-their-broken-research-labs/

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today